BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15894065)

  • 1. Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats.
    Kawakami Y; Kitamura Y; Araki H; Kitagawa K; Suemaru K; Shibata K; Gomita Y
    Pharmacol Biochem Behav; 2005 May; 81(1):65-70. PubMed ID: 15894065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats.
    Kitamura Y; Araki H; Suemaru K; Gomita Y
    Pharmacol Biochem Behav; 2002 May; 72(1-2):397-402. PubMed ID: 11900811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment-resistant depression: involvement of 5-HT(2A) receptors?
    Kitamura Y; Akiyama K; Kitagawa K; Shibata K; Kawasaki H; Suemaru K; Araki H; Sendo T; Gomita Y
    Pharmacol Biochem Behav; 2008 May; 89(3):235-40. PubMed ID: 18255130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
    Kitamura Y; Shibata K; Akiyama K; Kimoto S; Fujitani Y; Kitagawa K; Kanzaki H; Ouchida M; Shimizu K; Kawasaki H; Sendo T; Gomita Y
    J Pharmacol Sci; 2008 Jan; 106(1):100-6. PubMed ID: 18187923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
    Gorzalka BB; Hill MN; Sun JC
    Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.
    Kitamura Y; Fujitani Y; Kitagawa K; Miyazaki T; Sagara H; Kawasaki H; Shibata K; Sendo T; Gomita Y
    Biol Pharm Bull; 2008 Feb; 31(2):246-9. PubMed ID: 18239281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin.
    Landry M; Frasier M; Chen Z; Van De Kar LD; Zhang Y; Garcia F; Battaglia G
    Synapse; 2005 Nov; 58(2):102-9. PubMed ID: 16088947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of noradrenaline and serotonin reuptake inhibitors on pituitary-adrenocortical and sympatho-adrenomedullar system of adult rats.
    Dronjak S; Spasojevic N; Gavrilovic L; Varagic V
    Neuro Endocrinol Lett; 2007 Oct; 28(5):614-20. PubMed ID: 17984940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.
    Piacentini MF; Clinckers R; Meeusen R; Sarre S; Ebinger G; Michotte Y
    Life Sci; 2003 Sep; 73(19):2433-42. PubMed ID: 12954452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats.
    Umeda Y; Amano M; Suemaru K; Yamaguchi T; Kitamura Y; Gomita Y; Kawasaki H; Araki H
    Acta Med Okayama; 2007 Dec; 61(6):311-7. PubMed ID: 18183075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors.
    Kuroda Y; Mikuni M; Ogawa T; Takahashi K
    Psychopharmacology (Berl); 1992; 108(1-2):27-32. PubMed ID: 1384079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.